An investigation study of the glycemic index (GI): an open-label trial - An investigation study of the glycemic index (GI)

ORTHOMEDICO Inc.0 sites11 target enrollmentAugust 28, 2020

ConditionsHealthy Japanese subjects

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy Japanese subjects
Sponsor: ORTHOMEDICO Inc.
Enrollment: 11
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

August 28, 2020

End Date

October 31, 2020

Last Updated

last year

Study Type

Interventional

Sex

All

Investigators

Sponsor

ORTHOMEDICO Inc.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who have food allergies and/or food intolerances. Particularly, subjects who have lactose intolerance. 5\. Subjects who have abnormal glucose tolerance 6\. Subjects who take medications known to affect glucose tolerance 7\. Subjects who use insulin to treat diabetes or take antihyperglycemic drugs 8\. Subjects who have been hospitalized for treatment or surgery within the last three months 9\. Subjects who are the presence or under the treatment of disease which influence digestion and absorption of nutrients 10\. Subjects who are taking steroids, protease inhibitors, or antipsychotics 11\. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily 12\. Currently taking medicines (include herbal medicines) and supplements 13\. Subjects who are allergic to medicines and/or the test food related products 14\. Subjects who are pregnant, breast\-feeding, and planning to become pregnant 15\. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial 16\. Subjects who are judged as ineligible to participate in the study by the physician